创新药行业正迎来新一轮发展机遇。来源|药智网(ID: yaozh008)作者|杨柳儿今年以来,医药板块一改前几年“寒冬”景象,在众多板块中脱颖而出,涨幅傲视群雄。截至6月3日,今年A股和H股医药板块上涨明显,约70%企业股价上涨,多家药企股价实现翻倍增长。据药智网统计和铂医药、舒泰神、加科思、荣昌生物、三生制药、一品红等24家公司股价在今年实现翻倍式上涨。其中德琪医药股价上涨5倍多,成为今年...
Source Link创新药行业正迎来新一轮发展机遇。来源|药智网(ID: yaozh008)作者|杨柳儿今年以来,医药板块一改前几年“寒冬”景象,在众多板块中脱颖而出,涨幅傲视群雄。截至6月3日,今年A股和H股医药板块上涨明显,约70%企业股价上涨,多家药企股价实现翻倍增长。据药智网统计和铂医药、舒泰神、加科思、荣昌生物、三生制药、一品红等24家公司股价在今年实现翻倍式上涨。其中德琪医药股价上涨5倍多,成为今年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.